UrologyPub Date : 2024-11-01DOI: 10.1016/j.urology.2024.08.015
Devesh Misra , Mohamad E. Abdullah
{"title":"Telescoping the Dorsal Hood in Hypospadias Surgery: An Innovation to Preserve Maximal Penile Skin","authors":"Devesh Misra , Mohamad E. Abdullah","doi":"10.1016/j.urology.2024.08.015","DOIUrl":"10.1016/j.urology.2024.08.015","url":null,"abstract":"<div><h3>Objective</h3><div>To describe a new technique or adjunct—telescoping the dorsal hood—with a view to banking excess skin on the penile shaft in hypospadias surgery. This would help if redo surgery, not a rare occurrence, is required in the future.</div></div><div><h3>Method</h3><div>A review of a prospectively maintained database of hypospadias surgeries conducted between 1997 and 2023 by a single surgeon.</div><div>After the hypospadias repair, instead of excising the dorsal hood and suturing the ventral penile skin in the usual way, a skin hook is applied on the ventral penile skin in the midline. As the skin hook is pulled down towards the scrotum, anywhere from 1 to 4<!--> <!-->cm, it telescopes the dorsal hood down the penile shaft and also pulls in dorsal skin ventrally. (Technique described more fully in the manuscript)</div></div><div><h3>Results</h3><div>Around 1084 patients were operated for hypospadias over these 27 years. Telescoping of the dorsal hood was used in all patients, and in the 126 with proximal hypospadias, none had any skin of the dorsal hood excised!</div><div>Sixty-two patients presented later with 73 fistulae which were operated on. Of note, no patient needed more than 2 surgical attempts for a cure.</div></div><div><h3>Conclusion</h3><div>The dorsal hood is a useful source of not only skin but also underlying vascularised soft tissue. In hypospadias surgery where redo-operations are a predictable reality, preserving any excess skin on the phallus seems sensible. Our innovation of telescoping the dorsal hood achieves this goal nicely and takes only a few minutes to perform.</div></div>","PeriodicalId":23415,"journal":{"name":"Urology","volume":"193 ","pages":"Pages 182-185"},"PeriodicalIF":2.1,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141996628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
UrologyPub Date : 2024-11-01DOI: 10.1016/j.urology.2024.08.025
Andrew Allen , Kara McAbee , John V. Kryger
{"title":"Chromophobe Renal Cell Carcinoma in a Pediatric Patient With Neurofibromatosis Type 1: A Case Report and Review of the Literature","authors":"Andrew Allen , Kara McAbee , John V. Kryger","doi":"10.1016/j.urology.2024.08.025","DOIUrl":"10.1016/j.urology.2024.08.025","url":null,"abstract":"<div><div>Renal Cell Carcinoma is rare in the pediatric population, making up only 2%-6% of all pediatric renal tumors. Literature on pediatric Chromophobe Renal Cell Carcinoma (chRCC) is exceptionally limited. In this report, we describe the case of a 12-year-old patient with Neurofibromatosis Type 1 (NF1), incidentally found to have a kidney lesion with pathology revealing chRCC. Treatment included open partial nephrectomy with lymph node dissection and current follow-up is nearly 1 year. To our knowledge, this is the first case of chRCC in the setting of NF1.</div></div>","PeriodicalId":23415,"journal":{"name":"Urology","volume":"193 ","pages":"Pages e92-e95"},"PeriodicalIF":2.1,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142037140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
UrologyPub Date : 2024-11-01DOI: 10.1016/j.urology.2024.10.065
Fuad Elkhoury
{"title":"Editorial Comment on \"Variation in Urology Care After Urinary Stone Surgery Among Veterans at High-risk for Recurrence\".","authors":"Fuad Elkhoury","doi":"10.1016/j.urology.2024.10.065","DOIUrl":"10.1016/j.urology.2024.10.065","url":null,"abstract":"","PeriodicalId":23415,"journal":{"name":"Urology","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142569667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
UrologyPub Date : 2024-11-01DOI: 10.1016/j.urology.2024.07.019
Jennifer B. Gordetsky , Aida Valencia
{"title":"Editorial Comment on “Does Ta Low-grade Urothelial Carcinoma of the Bladder With Focal High-grade Features Carry Worse Prognosis? The Roswell Park Comprehensive Cancer Center Experience”","authors":"Jennifer B. Gordetsky , Aida Valencia","doi":"10.1016/j.urology.2024.07.019","DOIUrl":"10.1016/j.urology.2024.07.019","url":null,"abstract":"","PeriodicalId":23415,"journal":{"name":"Urology","volume":"193 ","pages":"Pages 143-144"},"PeriodicalIF":2.1,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141735123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
UrologyPub Date : 2024-11-01DOI: 10.1016/j.urology.2024.07.029
Nicolette G. Payne , Sayi P. Boddu , Kevin M. Wymer , Daniel J. Heidenberg , Charles Van Der Walt , Lanyu Mi , Mira Keddis , Karen L. Stern
{"title":"The Use of Genetic Testing in Nephrolithiasis Evaluation: A Retrospective Review From a Multidisciplinary Kidney Stone Clinic","authors":"Nicolette G. Payne , Sayi P. Boddu , Kevin M. Wymer , Daniel J. Heidenberg , Charles Van Der Walt , Lanyu Mi , Mira Keddis , Karen L. Stern","doi":"10.1016/j.urology.2024.07.029","DOIUrl":"10.1016/j.urology.2024.07.029","url":null,"abstract":"<div><h3>Objective</h3><div>To describe genetic and clinical characteristics for patients undergoing genetic testing at our multidisciplinary kidney stone clinic.</div></div><div><h3>Methods</h3><div>A retrospective review was performed on patients evaluated in our stone clinic and referred to genetics between 2018 and 2022. Patient demographic, clinical, stone, and genetic data were included. We assessed the specific variants identified in our cohort, both those with a pathogenic association and variants of unknown significance.</div></div><div><h3>Results</h3><div>Of 825 patients seen in our stone clinic from 2018-2022, 50 patients were referred to genetics. Among these patients, 33/50 (66%) underwent genetic testing and were included in the analysis. Of those who underwent genetic testing, a variant was identified in 19/33 (58%) patients, and 9/33 (27%) of these were a known pathogenic variant. Among patients with a pathogenic variant identified, the majority had a family history of stones (55.6%), calcium-based stones (77.8%), had their first stone prior to age 18 (66.7%), were recurrent stone formers (100%), and had been managed medically (88.9%) or surgically (88.9%) prior to testing. When comparing patients with a pathogenic variant, variants of unknown significance, and no variant, there were no significant differences in demographic or clinical parameters.</div></div><div><h3>Conclusion</h3><div>In our stone practice, more than half of patients who underwent genetic testing were found to have a variant. However, the majority of these variants were of unknown significance. Further evaluation regarding how genetic testing can impact nephrolithiasis management is needed.</div></div>","PeriodicalId":23415,"journal":{"name":"Urology","volume":"193 ","pages":"Pages 20-26"},"PeriodicalIF":2.1,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141761224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Letter to the Editor on “A Single Injection of Platelet-rich Plasma Injection for the Treatment of Stress Urinary Incontinence in Females: A Randomized Placebo-controlled Trial”","authors":"Vivek Rathod, Kirti Singh, Sambit Tripathy, Swarnendu Mandal, Manoj Kumar Das, Prasant Nayak","doi":"10.1016/j.urology.2024.07.056","DOIUrl":"10.1016/j.urology.2024.07.056","url":null,"abstract":"","PeriodicalId":23415,"journal":{"name":"Urology","volume":"193 ","pages":"Pages 71-72"},"PeriodicalIF":2.1,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141917569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
UrologyPub Date : 2024-11-01DOI: 10.1016/j.urology.2024.08.030
Bridget L. Findlay, Anthony Fadel, Sierra T. Pence, Cameron J. Britton, Brian J. Linder, Daniel S. Elliott
{"title":"Reply to Editorial Comment on “Natural History of Artificial Urinary Sphincter Erosion: Long-term Lower Urinary Tract Outcomes and Incontinence Management”","authors":"Bridget L. Findlay, Anthony Fadel, Sierra T. Pence, Cameron J. Britton, Brian J. Linder, Daniel S. Elliott","doi":"10.1016/j.urology.2024.08.030","DOIUrl":"10.1016/j.urology.2024.08.030","url":null,"abstract":"","PeriodicalId":23415,"journal":{"name":"Urology","volume":"193 ","pages":"Page 213"},"PeriodicalIF":2.1,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142056570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
UrologyPub Date : 2024-11-01DOI: 10.1016/j.urology.2024.06.054
Bridget L. Findlay, Anthony Fadel, Sierra T. Pence, Cameron J. Britton, Brian J. Linder, Daniel S. Elliott
{"title":"Natural History of Artificial Urinary Sphincter Erosion: Long-term Lower Urinary Tract Outcomes and Incontinence Management","authors":"Bridget L. Findlay, Anthony Fadel, Sierra T. Pence, Cameron J. Britton, Brian J. Linder, Daniel S. Elliott","doi":"10.1016/j.urology.2024.06.054","DOIUrl":"10.1016/j.urology.2024.06.054","url":null,"abstract":"<div><h3>Objective</h3><div>To describe long-term lower urinary tract<span> outcomes and incontinence management after AUS erosion, including risk factors associated with each outcome.</span></div></div><div><h3>Methods</h3><div><span>We retrospectively reviewed our prospectively maintained AUS database for men undergoing device explantation for urethral erosion from January 1, 1986 to October 10, 2023. Outcomes included development of urethral stricture and management of post-explant incontinence (eg, pads/clamp, catheter, salvage AUS, supravesical diversion). Risk factors were tested for association with stricture formation and repeat AUS erosion using </span>logistic regression.</div></div><div><h3>Results</h3><div>Around 1943 unique patients underwent AUS implantation during the study period, and 217 (11%) had a device explantation for urethral erosion. Of these, 194 had complete records available and were included for analysis. Median follow-up from implantation was 7.5 years (IQR 2.7-13.7) and median time to erosion was 2 yrs (IQR 0-6). Ninety-six patients (49%) underwent salvage AUS placement. Of those, 38/96 (40%) were explanted for subsequent erosion. On multivariable analysis, no factors were significantly associated with risk of salvage AUS erosion. On multivariable model, pelvic radiation (OR 2.7; 95% CI 1.0-7.4) and urethral reapproximation during explant for erosion (OR 4.2; 95% CI 1.5-11.2) were significantly associated with increased risk of urethral stricture (<em>P</em> <.05). At the time of last follow-up, 69/194 (36%) patients had a functioning salvage AUS, including both initial and subsequent salvage implants.</div></div><div><h3>Conclusion</h3><div>Following AUS erosion, radiation history and urethral reapproximation at explantation were risk factors for development of urethral stricture. Salvage AUS replacement can be performed, but has a higher rate of repeat urethral erosion.</div></div>","PeriodicalId":23415,"journal":{"name":"Urology","volume":"193 ","pages":"Pages 204-210"},"PeriodicalIF":2.1,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141471024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}